Attributes | Values |
---|
rdf:type
| |
Description
| - The aim of this study was to establish clinical proof of concept of hGH treatment for the improvement of the nutritional status in adult patients who are on maintenance hemodialysis. Change in LBM and serum albumin (primary outcomes), health-related quality of life, and secondary efficacy and safety parameters were monitored. There were no differences in clinically relevant adverse events between groups. In conclusion, hGH therapy safely improves LBM, other markers of mortality and morbidity, and health-related quality of life in adult patients who are on maintenance hemodialysis.
- The aim of this study was to establish clinical proof of concept of hGH treatment for the improvement of the nutritional status in adult patients who are on maintenance hemodialysis. Change in LBM and serum albumin (primary outcomes), health-related quality of life, and secondary efficacy and safety parameters were monitored. There were no differences in clinically relevant adverse events between groups. In conclusion, hGH therapy safely improves LBM, other markers of mortality and morbidity, and health-related quality of life in adult patients who are on maintenance hemodialysis. (en)
- Cílem této studie bylo poskytnout klinický důkaz o konceptu léčby růstovým hormonem (hGH) pro zlepšení nutričního stavu dospělých pacientů na hemodialýze. Studie prokázala, že hGH ve všech koncentracích zvyšoval LBM, sérový albumin, transferin a HDL zatímco plazmatický homocystein a TNF-alfa se snižoval. Byla také pozorována zlepšená podškála the role physical SF-36 quality of life. Nebyly pozorovány rozdíly v klinicky relevantních nežádoucích účincích mezi skupinami. Závěrem lze říci, že léčba hGH bezpečně zlepšuje LBM a ostatní ukazatele morbidity a mortality u pacientů, kteří jsou na udržovací hemodialýze. (cs)
|
Title
| - Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life and Cardiovacular Risk
- Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life and Cardiovacular Risk (en)
- Léčba růstovým hormonem během dialýzy jako pokus o zlepšení nutrice, kvality života a kardiovaskulárního rizika (cs)
|
skos:prefLabel
| - Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life and Cardiovacular Risk
- Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life and Cardiovacular Risk (en)
- Léčba růstovým hormonem během dialýzy jako pokus o zlepšení nutrice, kvality života a kardiovaskulárního rizika (cs)
|
skos:notation
| - RIV/00216208:11150/07:00003948!RIV08-MSM-11150___
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11150/07:00003948
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Growth; Hormone; Treatment; during; Hemodialysis; Randomized; Trial; Improves; Nutrition; Quality; Cardiovacular; Risk (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of the American Society of Nephrology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |